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Objective Achilles tendon pathology (ATP) is a multifactorial condition with a recognised 
genetic component. The MMP-3 enzyme regulates extracellular matrix homeostasis by 
degrading various types of collagens. The matrix metalloproteinase 3 (MMP3) gene has 
previously been associated with the risk of developing ATP in a South African Caucasian 
population. The purpose of this study was to determine whether the MMP3 rs679620 variant 
that was associated with ATP in South Africans was also a risk factor for ATP in a recently 
recruited British Caucasian population.  We also sought to establish, in a preliminary 
manner, whether the variant was associated with additional clinicopatholigical characteristics 
of our cohort. 
Methods 252 (121 cases with ATP and 131 asymptomatic controls) British Caucasian 
participants were recruited for this case-control genetic association study. All participants 
were genotyped for the MMP3 G/A rs679620 variant using TaqMan technology. Data was 
analysed using chi-squared and ANOVA tests with significance set at p<0.05. 
Results There was no significant (p=0.349) difference in genotype distribution frequency 
between the ATP and control groups. However, when we restricted our analysis to include 
only individuals with Achilles tendon rupture, we found a significant (p=0.029) difference in 
genotype distribution frequency between this group (AA, 31.4%; AG, 31.4%; GG, 37.1%) 
and the controls (AA, 26.7%; AG, 54.2%; GG, 19.1%). Furthermore, we found that male 
participants with tendinosis and the GG genotype had significantly (p=0.007) thicker Achilles 
tendons compared to the AG and AA genotypes.   
Conclusion This study shows that the MMP3 rs679620 variant was not associated with ATP 
when the condition was analysed as a single clinical entity. However, we did show that the 
GG genotype was significantly associated with both the risk of Achilles tendon rupture and 
increased tendon width in males with tendinosis. Although these data show some contrasts 
with a previously published study in South Africans they do enhance our understanding of 
the role of the MMP3 rs679620 variant in predisposing to Achilles tendon injury. 
